Fluid and Intravenous Therapy: Crystalloids, Colloids, and Clinical Management

Understanding fluid therapy requires a thorough grasp of body fluid distribution and regulation. Total body water (TBW) comprises approximately 60% of body weight in adult males and 50% in adult females, with variations based on age, body composition, and pathological states.

Body Fluid Compartments:

• Intracellular fluid (ICF): ~40% of body weight (67% of TBW)
• Extracellular fluid (ECF): ~20% of body weight (33% of TBW)
  • Intravascular (plasma): ~5% of body weight (25% of ECF)
  • Interstitial: ~15% of body weight (75% of ECF)

Osmolarity and Tonicity: Plasma osmolality normally ranges from 280-295 mOsm/kg H₂O, primarily determined by sodium (Na⁺), glucose, and blood urea nitrogen (BUN). The calculated osmolarity formula is: 2[Na⁺] + [Glucose]/18 + [BUN]/2.8 (all in mmol/L).

Starling Forces: Fluid movement across capillary membranes follows Starling's law: Net filtration = Kf[(Pc - Pi) - σ(πc - πi)]

• Pc = capillary hydrostatic pressure
• Pi = interstitial hydrostatic pressure
• πc = capillary oncotic pressure
• πi = interstitial oncotic pressure
• σ = reflection coefficient
• Kf = filtration coefficient

Albumin, the primary oncotic agent, maintains approximately 75% of plasma oncotic pressure (normally 25-28 mmHg). Understanding these principles guides rational fluid selection and dosing strategies in clinical practice.

Crystalloids are aqueous solutions containing small molecules (electrolytes, glucose) that freely cross semipermeable membranes. They represent the first-line fluid therapy in most clinical scenarios due to their safety profile, cost-effectiveness, and physiological compatibility.

Isotonic Crystalloids:

Distribution and Kinetics: Isotonic crystalloids distribute throughout the ECF space within 30-60 minutes. Approximately 25% remains intravascular, while 75% shifts to the interstitial space. This distribution pattern explains why 3-4 mL of isotonic crystalloid is required to replace each 1 mL of blood loss.

Hypotonic Solutions:

• 0.45% NaCl (half-normal saline): Osmolality ~154 mOsm/kg
• 5% Dextrose in water (D5W): Initially isotonic, becomes hypotonic after glucose metabolism

Hypertonic Solutions:

• 3% NaCl: Used for severe hyponatremia (Na⁺ <120 mmol/L with neurological symptoms)
• 7.5% NaCl: Emergency resuscitation in hemorrhagic shock

Clinical Considerations: Normal saline contains supraphysiological chloride concentrations, potentially causing hyperchloremic metabolic acidosis. Balanced crystalloids (Lactated Ringer's, Plasma-Lyte) more closely approximate plasma electrolyte composition and may reduce the risk of acute kidney injury in critically ill patients.

Colloids contain large molecular weight substances that remain predominantly intravascular, providing sustained volume expansion with smaller infusion volumes compared to crystalloids. However, their clinical benefits remain controversial, with recent evidence questioning routine use.

Natural Colloids:

Human Albumin:

• Molecular weight: 69 kDa
• Normal plasma concentration: 35-50 g/L
• Half-life: 21 days (in healthy individuals)
• Volume expansion: 1:1 ratio (1 L albumin ≈ 1 L plasma volume expansion)
• Indications: Severe hypoalbuminemia (<20 g/L), hepatorenal syndrome, paracentesis >5L

Synthetic Colloids:

Current Evidence and Recommendations: The SAFE, FEAST, and CRISTAL trials demonstrated no mortality benefit of colloids over crystalloids in critically ill patients. The CHEST study showed increased mortality with HES in septic patients. Current guidelines recommend:

1. Crystalloids as first-line therapy for most indications
2. Albumin consideration in patients with hypoalbuminemia and hemodynamic instability
3. Avoid HES in sepsis and critically ill patients
4. Reserve colloids for specific indications where crystalloid therapy is inadequate

Economic Considerations: Colloids cost 10-100 times more than crystalloids, with questionable clinical benefit in most scenarios, making crystalloids the preferred choice from both clinical and economic perspectives.

Maintenance fluid therapy replaces normal physiological losses and maintains fluid-electrolyte homeostasis in patients unable to maintain adequate oral intake.

Holliday-Segar Method (Pediatric and Adult):

Daily Fluid Requirements: • First 10 kg: 100 mL/kg/day • Next 10 kg (10-20 kg): 50 mL/kg/day
• Each kg >20 kg: 20 mL/kg/day

Hourly Rate Calculation: • First 10 kg: 4 mL/kg/hr • Next 10 kg: 2 mL/kg/hr • Each kg >20 kg: 1 mL/kg/hr

Example Calculation (70 kg adult):

• First 10 kg: 10 × 4 = 40 mL/hr
• Next 10 kg: 10 × 2 = 20 mL/hr
• Remaining 50 kg: 50 × 1 = 50 mL/hr
• Total: 110 mL/hr or 2640 mL/day

Maintenance Fluid Algorithm:

Patient Assessment ↓ NPO Status + Normal Losses ↓ Calculate Maintenance Rate (Holliday-Segar) ↓ Select Appropriate Fluid: • D5W + 20 mEq KCl/L (if normal renal function) • D5 1/2 NS + 20 mEq KCl/L (most common) • Adjust based on:

• Serum sodium levels
• Renal function
• Cardiac status
• Ongoing losses

Electrolyte Requirements:

• Sodium: 2-3 mEq/kg/day
• Potassium: 1-2 mEq/kg/day
• Chloride: 2-3 mEq/kg/day

Special Considerations:

• Elderly patients: Reduce maintenance by 20-25% due to decreased total body water
• Heart failure: Consider 75% of calculated maintenance
• Renal impairment: Adjust potassium and monitor closely
• Fever: Increase maintenance by 10% for each degree >37°C

Monitoring Parameters:

• Daily weights (most sensitive indicator)
• Input/output balance
• Vital signs and hemodynamic status
• Serum electrolytes (daily initially)
• Urine output (goal: >0.5 mL/kg/hr in adults)

Fluid resuscitation aims to restore adequate tissue perfusion and oxygen delivery in patients with various shock states. The approach varies significantly based on shock etiology and patient characteristics.

Initial Assessment and Resuscitation Algorithm:

Shock Recognition (SBP <90 mmHg, MAP <65 mmHg, or >40 mmHg decrease from baseline) ↓ Rapid Assessment: • Hypovolemic: ↓CVP, ↓PCWP, ↑SVR • Cardiogenic: ↑CVP, ↑PCWP, ↑SVR • Distributive: ↓SVR, ±↑/↓CVP • Obstructive: ↑CVP, ↓CO ↓ Fluid Challenge Protocol

Hypovolemic Shock Resuscitation:

Initial Bolus:

• Adults: 1-2 L crystalloid over 15-30 minutes
• Pediatrics: 20 mL/kg over 10-20 minutes
• Reassess after each bolus

3:1 Rule: For hemorrhagic shock, administer 3 mL crystalloid for every 1 mL estimated blood loss

Septic Shock Protocol (Surviving Sepsis Guidelines):

Hour 0-1: • 30 mL/kg crystalloid bolus • Obtain cultures, lactate • Initiate antibiotics

Hour 1-6: • Reassess volume status • Additional fluid if:

• MAP <65 mmHg
• Lactate >2 mmol/L
• Signs of tissue hypoperfusion • Consider vasopressors if inadequate response

Fluid Responsiveness Assessment:

Goals of Resuscitation:

• Mean arterial pressure (MAP) >65 mmHg
• Central venous pressure 8-12 mmHg
• Urine output >0.5 mL/kg/hr
• Central venous oxygen saturation (ScvO₂) >70%
• Lactate clearance >10% within 6 hours

Balanced vs. Liberal Fluid Strategy: Recent evidence (CLASSIC, CLOVERS trials) suggests restrictive fluid strategies may improve outcomes in certain populations, emphasizing the importance of individualized approaches rather than protocol-driven resuscitation.

Electrolyte disorders are common in hospitalized patients and require systematic approaches to diagnosis, treatment, and monitoring. Understanding replacement strategies prevents complications and optimizes patient outcomes.

Hyponatremia Management:

Serum Na⁺ <135 mmol/L ↓ Assess Volume Status: • Hypovolemic: ↓skin turgor, dry mucous membranes • Euvolemic: Normal examination • Hypervolemic: Edema, elevated JVP ↓ Treatment Algorithm: Hypovolemic → Normal saline Euvolemic → Water restriction Hypervolemic → Diuretics + water restriction

Severe (Na⁺ <120 mmol/L + neurologic symptoms): → 3% NaCl at 0.5-2 mL/kg/hr → Target: 4-6 mmol/L increase in first 24 hours → Maximum: 8 mmol/L increase in 24 hours

Hypernatremia Correction:

• Water deficit calculation: 0.6 × weight (kg) × (([Na⁺] - 140)/140)
• Replace over 48-72 hours
• Use D5W or hypotonic saline
• Target reduction: 0.5 mmol/L/hr (maximum 10 mmol/L/24 hr)

Potassium Replacement Protocol:

IV Potassium Guidelines:

• Maximum peripheral concentration: 40 mEq/L
• Maximum central line concentration: 60 mEq/L
• Maximum infusion rate: 10 mEq/hr (peripheral), 20 mEq/hr (central)
• Continuous cardiac monitoring if rate >10 mEq/hr

Magnesium Replacement:

Hypomagnesemia (Mg²⁺ <0.75 mmol/L) ↓ Symptomatic or Mg²⁺ <0.5 mmol/L: • MgSO₄ 1-2 g IV over 15-60 minutes • Repeat based on levels

Asymptomatic: • MgO 400-800 mg PO daily • Monitor closely if concurrent hypokalemia

Monitoring and Safety:

• Recheck electrolytes 4-6 hours after IV replacement
• Daily monitoring until stable
• Assess renal function before aggressive replacement
• Consider underlying causes (medications, GI losses, endocrine disorders)

Fluid management requires modification in specific patient populations and clinical scenarios due to altered physiology, comorbidities, and variable responses to standard protocols.

Pediatric Fluid Management:

Age-Related Differences:

• Higher body water percentage (75% in neonates vs. 60% in adults)
• Increased insensible losses (respiratory rate, body surface area)
• Immature renal concentrating ability
• Greater risk of rapid dehydration

Dehydration Assessment in Children:

Cardiac Patients:

Fluid Management in Heart Failure: ↓ Assess Volume Status: • Clinical: JVP, edema, lung sounds • Laboratory: BNP/NT-proBNP • Imaging: CXR, echo ↓ Volume Overloaded: • Diuretics (furosemide 40-80 mg IV) • Fluid restriction <2 L/day • Daily weights

Volume Depleted (rare): • Cautious crystalloid challenge • 250-500 mL over 1-2 hours • Reassess frequently

Renal Disease:

• AKI: Avoid nephrotoxic solutions, monitor UOP closely
• CKD: Phosphate-free solutions, potassium restriction
• Dialysis: Fluid restriction between sessions

Surgical Patients:

Perioperative Fluid Strategy:

• Goal-Directed Therapy: Use dynamic indicators (SVV, PPV) to guide fluid administration
• Enhanced Recovery Protocols: Liberal perioperative fluids, restrictive postoperative approach
• Third Space Losses: Additional 5-10 mL/kg/hr for major abdominal surgery

Burn Patients (Parkland Formula):

• First 24 hours: 4 mL/kg × %BSA burned
• Give 50% in first 8 hours, remaining 50% over next 16 hours
• Use Lactated Ringer's solution
• Monitor urine output (goal: 0.5-1.0 mL/kg/hr)

Pregnancy Considerations:

• Increased plasma volume by 40-50%
• Risk of aortocaval compression
• Avoid excessive saline (risk of pulmonary edema)
• Consider albumin in preeclampsia with severe hypoalbuminemia